Related Experiment Video
Updated: Oct 15, 2025

Use of In vivo Imaging to Monitor the Progression of Experimental Mouse Cytomegalovirus Infection in Neonates
Published on: July 6, 2013
Congenital Cytomegalovirus and Hepatic Failure: An Underrecognized Complication
J Paige Souder1, Erica Grimm2, Swetha Pinninti3
1From the Medical Scientist Training Program, University of Alabama at Birmingham, Birmingham.
Insights
Congenital cytomegalovirus (CMV) infection, the most common congenital infection, can cause hepatitis. This study highlights two term infants who developed liver failure despite early antiviral treatment for CMV hepatitis.
Area of Science:
- Virology
- Hepatology
- Neonatal Medicine
Background:
- Congenital cytomegalovirus (CMV) infection is the leading cause of congenital viral infections.
- While often asymptomatic, CMV can manifest with hepatitis in newborns.
- Hepatic failure progression in term infants treated early for congenital CMV hepatitis is not well-documented.
Observation:
- Two term infants with congenital CMV infection and hepatitis were studied.
- Both infants showed initial laboratory improvement with antiviral therapy.
- Despite treatment, both infants progressed to severe hepatic failure.
Findings:
- Congenital CMV infection can lead to progressive hepatitis and hepatic failure in term infants.
- Early antiviral treatment may not prevent the progression to liver failure in all cases.
- This progression occurred despite initial positive responses to therapy.
Implications:
- Congenital CMV hepatitis requires careful monitoring for potential progression to liver failure, even with treatment.
- Current antiviral strategies may need re-evaluation for preventing severe outcomes in congenital CMV.
- Further research is needed to understand risk factors and optimize management for congenital CMV-induced liver disease.
Abstract:
Congenital cytomegalovirus infection is the most common congenital infection. Although most infants with congenital cytomegalovirus infection are asymptomatic at birth, a subset will have readily apparent clinical and/or laboratory manifestations including hepatitis; progression to hepatic failure has not previously been described in term infants who initiated antiviral treatment shortly after birth. We present 2 term infants with congenital cytomegalovirus infection and hepatitis who progressed to hepatic failure despite initial laboratory improvement on therapy.
More Related Videos
05:51Intracerebroventricular and Intravascular Injection of Viral Particles and Fluorescent Microbeads into the Neonatal Brain
Published on: July 24, 2016
05:56Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis
Published on: August 29, 2025
Related Concept Videos
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Immunodeficiency Diseases
There are three main causes of immunodeficiency...
Hepatic Portal System
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
Inborn Errors of Metabolism